Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Elena P Calandre, Fernando Rico-Villademoros & Mahmoud Slim. (2015) An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opinion on Pharmacotherapy 16:9, pages 1347-1368.
Read now
Read now
Mustafa Arı, Yasin Bez, Mehmet Cemal Kaya, Fatma Aslan & Hayal Guler. (2012) Childhood Abuse and Anxiety in Treatment-Resistant Fibromyalgia Syndrome. MYOPAIN 0:0, pages 1-5.
Read now
Read now
Kim Francis Le Marshall & Geoffrey Owen Littlejohn. (2011) Management strategies for fibromyalgia. Open Access Rheumatology: Research and Reviews 3, pages 47-51.
Read now
Read now
Matthias F Seidel & Wolfgang Müller. (2011) Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists. Expert Opinion on Pharmacotherapy 12:9, pages 1381-1391.
Read now
Read now
Ali Gur & Pelin Oktayoglu. (2009) Advances in diagnostic and treatment options in patients with fibromyalgia syndrome. Open Access Rheumatology: Research and Reviews 1, pages 193-209.
Read now
Read now
Richard E Harris & Daniel J Clauw. (2008) Newer treatments for fibromyalgia syndrome. Therapeutics and Clinical Risk Management 4:6, pages 1331-1342.
Read now
Read now
Grazyna Zareba. (2008) New treatment options in the management of fibromyalgia: role of pregabalin. Neuropsychiatric Disease and Treatment 4:6, pages 1193-1201.
Read now
Read now
Edward J. Calabrese. (2008) Pain and U-Shaped Dose Responses: Occurrence, Mechanisms, and Clinical Implications. Critical Reviews in Toxicology 38:7, pages 579-590.
Read now
Read now
Patrick B Wood, Andrew J Holman & Kim D Jones. (2007) Novel pharmacotherapy for fibromyalgia. Expert Opinion on Investigational Drugs 16:6, pages 829-841.
Read now
Read now
Richard N. Podell. (2007) Fibromyalgia Syndrome's New Paradigm: Neural Sensitization and Its Implications for Treatment. Journal of Musculoskeletal Pain 15:2, pages 45-54.
Read now
Read now
Gary McCleane. (2005) Emerging trends in the management of neuropathic pain. Expert Review of Neurotherapeutics 5:5, pages 617-623.
Read now
Read now
Gary McCleane. (2005) Do 5HT3 Antagonists Antinociceptive Have an Effect?. Journal of Neuropathic Pain & Symptom Palliation 1:1, pages 101-107.
Read now
Read now
Gary McCleane, Rie Suzuki & Anthony Dickenson. (2005) The 5HT3 Receptor Antagonist Ondansetron Can Have an Analgesic Effect in Chronic Human Neuropathic Pain. Journal of Neuropathic Pain & Symptom Palliation 1:1, pages 77-79.
Read now
Read now
M Späth, T Stratz, G Neeck, I Kötter, B Hammel, CC Amberger, U Haus, L Färber, D Pongratz & W Müller. (2004) Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scandinavian Journal of Rheumatology 33:4, pages 267-270.
Read now
Read now
J Tolk, R Kohnen & W Müller. (2004) Intravenous treatment of fibromyalgia with the 5‐HT3 receptor antagonist tropisetron in a rheumatological practice. Scandinavian Journal of Rheumatology 33:sup119, pages 72-75.
Read now
Read now
R Kohnen, L Färber & M Späth. (2004) The assessment of vegetative and functional symptoms in fibromyalgia patients: the tropisetron experience. Scandinavian Journal of Rheumatology 33:sup119, pages 67-71.
Read now
Read now
M Späth, T Stratz, L Färber, U Haus & D Pongratz. (2004) Treatment of fibromyalgia with tropisetron – dose and efficacy correlations. Scandinavian Journal of Rheumatology 33:sup119, pages 63-66.
Read now
Read now
W Müller & T Stratz. (2004) Local treatment of tendinopathies and myofascial painsyndromes with the 5‐HT3 receptor antagonist tropisetron. Scandinavian Journal of Rheumatology 33:sup119, pages 44-48.
Read now
Read now
T Stratz, B Fiebich, U Haus & W Müller. (2004) Influence of tropisetron on the serum substance P levels in fibromyalgia patients. Scandinavian Journal of Rheumatology 33:sup119, pages 41-43.
Read now
Read now
EM Schneider, X Ma, T Stratz, W Müller, I Lorenz & WD Seeling. (2004) Immunomodulatory function of the 5‐HT3 receptor antagonist tropisetron. Scandinavian Journal of Rheumatology 33:sup119, pages 34-40.
Read now
Read now
U Haus, M Späth & L Färber. (2004) Spectrum of use and tolerability of 5‐HT3 receptor antagonists. Scandinavian Journal of Rheumatology 33:sup119, pages 12-18.
Read now
Read now
Articles from other publishers (50)
Ryan Patel & Anthony H. Dickenson. (2018) Modality selective roles of pro-nociceptive spinal 5-HT2A and 5-HT3 receptors in normal and neuropathic states. Neuropharmacology 143, pages 29-37.
Crossref
Crossref
Nastaran Kordjazy, Arya Haj-Mirzaian, Shayan Amiri, Sattar Ostadhadi, Hossein Amini-khoei & Ahmad Reza Dehpour. (2016) Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test. Pharmacology Biochemistry and Behavior 141, pages 1-9.
Crossref
Crossref
Gary W. Jay & Robert L. Barkin. (2015) Fibromyalgia. Disease-a-Month 61:3, pages 66-111.
Crossref
Crossref
Janice E. Sumpton & Dwight E. Moulin. 2014. Neurologic Aspects of Systemic Disease Part I. Neurologic Aspects of Systemic Disease Part I
513
527
.
Iboro C. Umana, Claire A. Daniele & Daniel S. McGehee. (2013) Neuronal nicotinic receptors as analgesic targets: It's a winding road. Biochemical Pharmacology 86:8, pages 1208-1214.
Crossref
Crossref
Claudia Sommer, Winfried Häuser, Rieke H. F. Alten, Franz Petzke, Michael Späth, Thomas Tölle, Nurcan Üçeyler, Andreas Winkelmann, Eva Winter & Karl-Jürgen Bär. (2013) Das Fibromyalgiesyndrom: Was hilft wirklich?. CME 10:6, pages 61-74.
Crossref
Crossref
Elina Tiippana, Katri Hamunen, Vesa Kontinen & Eija Kalso. (2012) The Effect of Paracetamol and Tropisetron on Pain: Experimental Studies and a Review of Published Data. Basic & Clinical Pharmacology & Toxicology 112:2, pages 124-131.
Crossref
Crossref
Christian Stratz, Harsharan S. Bhatia, Ravi Shankar Akundi, Thomas Nührenberg, Dietmar Trenk, Eduardo Muñoz & Bernd L. Fiebich. (2012) The anti-inflammatory effects of the 5-HT3 receptor antagonist tropisetron are mediated by the inhibition of p38 MAPK activation in primary human monocytes. International Immunopharmacology 13:4, pages 398-402.
Crossref
Crossref
C. Sommer, W. Häuser, R. Alten, F. Petzke, M. Späth, T. Tölle, N. Üçeyler, A. Winkelmann, E. Winter & K.J. Bär. (2012) Medikamentöse Therapie des FibromyalgiesyndromsDrug therapy of fibromyalgia syndrome. Der Schmerz 26:3, pages 297-310.
Crossref
Crossref
Alban Y. Neziri, Martina Dickenmann, Pasquale Scaramozzino, Ole K. Andersen, Lars Arendt-Nielsen, Anthony H. Dickenson & Michele Curatolo. (2012) Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients. Pain 153:2, pages 311-318.
Crossref
Crossref
Oliver Bandschapp, Joerg Filitz, Albert Urwyler, Wolfgang Koppert & Wilhelm Ruppen. (2011) Tropisetron blocks analgesic action of acetaminophen: A human pain model study. Pain 152:6, pages 1304-1310.
Crossref
Crossref
Pascale Vergne‐Sallel, Carine Dufauret‐Lombardl, Christine Bonnetl, Anne Simonl, Richard Trèvesl, Henri Bonnabaul & Philippe Bertinl. (2012) A randomised, double‐blind, placebo‐controlled trial of dolasetron, a 5‐hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. European Journal of Pain 15:5, pages 509-514.
Crossref
Crossref
Daniel J. Clauw. 2011. Rheumatology. Rheumatology
769
782.e3
.
BaoXi Gao, Markus Hierl, Kristie Clarkin, Todd Juan, Hung Nguyen, Marissa van der Valk, Hong Deng, Wenhong Guo, Sonya G. Lehto, David Matson, Jeff S. McDermott, Johannes Knop, Kevin Gaida, Lei Cao, Dan Waldon, Brian K. Albrecht, Alessandro A. Boezio, Katrina W. Copeland, Jean-Christophe Harmange, Stephanie K. Springer, Annika B. Malmberg & Stefan I. McDonough. (2010) Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain. Pain 149:1, pages 33-49.
Crossref
Crossref
Claudia Sommer. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
457
471
.
William S. Wilke, Abby Abelson & Ravindran Padmanabhan. 2010. Current Clinical Medicine. Current Clinical Medicine
1124
1128.e1
.
Lesley M. Arnold. (2009) Strategies for Managing Fibromyalgia. The American Journal of Medicine 122:12, pages S31-S43.
Crossref
Crossref
Malin Ernberg. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia
243
274
.
Daniel Clauw. 2009. Fibromyalgia. Fibromyalgia
1
25
.
Michael Schneider, Howard Vernon, Gordon Ko, Gordon Lawson & Jerome Perera. (2009) Chiropractic Management of Fibromyalgia Syndrome: A Systematic Review of the Literature. Journal of Manipulative and Physiological Therapeutics 32:1, pages 25-40.
Crossref
Crossref
Lucy Bee & Anthony Dickenson. 2009. Synaptic Plasticity in Pain. Synaptic Plasticity in Pain
307
335
.
Lucy A. Bee & Anthony H. Dickenson. (2008) Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin. Pain 140:1, pages 209-223.
Crossref
Crossref
A. C. Dutton & N. M. Barnes. 2008. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
171
212
.
M. Martinez-Lavin. (2008) Dysfonctions du système nerveux sympathique dans la fibromyalgieSympathetic nervous system dysfunction in fibromyalgia. Douleur et Analgésie 20:4, pages 219-226.
Crossref
Crossref
W. Müller, M. Schneider, T. Joos, H.Y. Hsu & T. Stratz. (2007) Ein Modell zur Einteilung des FibromyalgiesyndromsSubgroups of fibromyalgia. Der Schmerz 21:5, pages 424-429.
Crossref
Crossref
W. Müller, E. M. Schneider & T. Stratz. (2007) The classification of fibromyalgia syndrome. Rheumatology International 27:11, pages 1005-1010.
Crossref
Crossref
R. Norman Harden, Gadi Revivo, Sharon Song, Devi Nampiaparampil, Gary Golden, Marie Kirincic & Timothy T. Houle. (2007) A Critical Analysis of the Tender Points in Fibromyalgia. Pain Medicine 8:2, pages 147-156.
Crossref
Crossref
Gerhard Fürst. (2007) Das Fibromyalgie-Syndrom: eine interdisziplinäre Herausforderung – Verlegenheitsdiagnose, Volksseuche oder Modekrankheit?Fibromyalgia – A challenge for interdisciplinary management. Wiener Medizinische Wochenschrift 157:1-2, pages 27-33.
Crossref
Crossref
Wissam El-Hage, Céline Lamy, Philippe Goupille, Philippe Gaillard & Vincent Camus. (2006) Fibromyalgie : une maladie du traumatisme psychique ?. La Presse Médicale 35:11, pages 1683-1689.
Crossref
Crossref
Rie Suzuki, Frank Porreca & Anthony H. Dickenson. (2006) Evidence for spinal dorsal horn hyperexcitability in rats following sustained morphine exposure. Neuroscience Letters 407:2, pages 156-161.
Crossref
Crossref
W. Müller, B. L. Fiebich & T. Stratz. (2006) 5-HT3-Rezeptor-Antagonisten als Analgetika bei rheumatischen Erkrankungen5-HT3 receptor antagonists als analgetics in rheumatic diseases. Zeitschrift für Rheumatologie 65:6, pages 546-552.
Crossref
Crossref
Robert N. Freedenfeld, Michelle Murray, Perry N. Fuchs & R. Sanford Kiser. (2006) Decreased Pain and Improved Quality of Life in Fibromyalgia Patients Treated with Olanzapine, an Atypical Neuroleptic. Pain Practice 6:2, pages 112-118.
Crossref
Crossref
E´ric Houvenagel. (2006) Fibromyalgie. EMC - Appareil locomoteur 1:1, pages 1-8.
Crossref
Crossref
Cayetano Alegre de Miquel, Claudia Alejandra-Pereda, María Betina-Nishishinya & Javier Rivera. (2005) Revisión sistemática de las intervenciones farmacológicas en la fibromialgia. Medicina Clínica 125:20, pages 784-787.
Crossref
Crossref
W. Brückle & H. Zeidler. (2005) Fibromyalgie — Ein UpdateFibromyalgia — An update. Der Internist 46:11, pages 1188-1197.
Crossref
Crossref
Rie Suzuki & Anthony Dickenson. (2005) Spinal and Supraspinal Contributions to Central Sensitization in Peripheral Neuropathy. Neurosignals 14:4, pages 175-181.
Crossref
Crossref
Rie Suzuki, Wahida Rahman, Stephen P Hunt & Anthony H Dickenson. (2004) Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Research 1019:1-2, pages 68-76.
Crossref
Crossref
Luiza Guilherme & Jorge Kalil. (2004) Rheumatic Fever: From Sore Throat to Autoimmune Heart Lesions. International Archives of Allergy and Immunology 134:1, pages 56-64.
Crossref
Crossref
Harald Murck. (2014) Atypical depression spectrum disorder – neurobiology and treatment. Acta Neuropsychiatrica 15:4, pages 227-241.
Crossref
Crossref
Serge Perrot. (2003) Des médicaments pour traiter la fibromyalgie ?. Revue du Rhumatisme 70:4, pages 340-345.
Crossref
Crossref
Éric Houvenagel. (2003) Physiopathologie de la douleur de la fibromyalgie. Revue du Rhumatisme 70:4, pages 314-320.
Crossref
Crossref
E. Houvenagel. (2003) Fibromialgia. EMC - Aparato Locomotor 36:2, pages 1-8.
Crossref
Crossref
Manuel Martı́nez-Lavı́n. (2002) Management of dysautonomia in fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 379-387.
Crossref
Crossref
Michael Späth. (2002) Current experience with 5-HT3 receptor antagonists in fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 319-328.
Crossref
Crossref
André Barkhuizen. (2002) Rational and targeted pharmacologic treatment of fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 261-290.
Crossref
Crossref
Srinivas G Rao. (2002) The neuropharmacology of centrally-acting analgesic medications in fibromyalgia. Rheumatic Disease Clinics of North America 28:2, pages 235-259.
Crossref
Crossref
Lisa J Miller & Kristy L Kubes. (2016) Serotonergic Agents in the Treatment of Fibromyalgia Syndrome. Annals of Pharmacotherapy 36:4, pages 707-712.
Crossref
Crossref
Dan Buskila & Joseph Press. (2001) Neuroendocrine mechanisms in fibromyalgia–chronic fatigue. Best Practice & Research Clinical Rheumatology 15:5, pages 747-758.
Crossref
Crossref
F. Kees, L. Färber, M. Bucher, G. Mair, K. Mörike & H. Grobecker. (2002) Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers. British Journal of Clinical Pharmacology 52:6, pages 705-707.
Crossref
Crossref
Frank P Bymaster, Julie F Falcone, Delbert Bauzon, John S Kennedy, Kathryn Schenck, Neil W DeLapp & Marlene L Cohen. (2001) Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine. European Journal of Pharmacology 430:2-3, pages 341-349.
Crossref
Crossref